LANCL2 and glioblastoma: Surprisingly, multivariate analysis showed that gender (p = 0.002, HR = 2.029) and LANCL2 amplification (p = 0.043, HR = 1.657) were independent significant prognostic factors for OS in younger GBM patients (Table 4).